MENU
+Compare
RSCF
Stock ticker: OTC
AS OF
Nov 13 closing price
Price
$0.05
Change
-$0.00 (-0.00%)
Capitalization
4.16M

RSCF stock forecast, quote, news & analysis

Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market... Show more

RSCF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for RSCF with price predictions
Nov 13, 2025

RSCF sees its Stochastic Oscillator climbs out of oversold territory

On November 11, 2025, the Stochastic Oscillator for RSCF moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 74 instances where the indicator left the oversold zone. In of the 74 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 13, 2025. You may want to consider a long position or call options on RSCF as a result. In of 117 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RSCF advanced for three days, in of 167 cases, the price rose further within the following month. The odds of a continued upward trend are .

RSCF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for RSCF turned negative on November 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for RSCF moved below the 200-day moving average on October 27, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RSCF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RSCF entered a downward trend on November 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.970) is normal, around the industry mean (10.086). P/E Ratio (0.000) is within average values for comparable stocks, (153.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.600). RSCF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.415) is also within normal values, averaging (110.982).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RSCF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RSCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 12B. The market cap for tickers in the group ranges from 246 to 200.47B. ISRG holds the highest valuation in this group at 200.47B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 2%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 6%. TUTH experienced the highest price growth at 133%, while SMTI experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was 91% and the average quarterly volume growth was 68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 61
Price Growth Rating: 59
SMR Rating: 80
Profit Risk Rating: 92
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
RSCF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1266 South 1380 West
Phone
+1 801 226-4100
Employees
8
Web
https://www.reflectscientific.com